Revolutionary advancements in blood cancer treatment, from targeted therapy to gene editing, promise more effective and ...

With Nigeria home to the highest number of people living with sickle cell disease (SCD) globally, health experts have called for curative therapies such as ...

The hair follicles of recipients of allogeneic hematopoietic SCT (HSCT) constitute the tissue with the greatest need for regeneration after high-dose chemotherapy. Previous studies have shown a ...

Frédéric B Piel et al, Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission, The Lancet Haematology (2023). DOI: 10.1016/S2352-3026(23)00096-0.

This article explains how to interpret haematology results to inform diagnosis and management, with a focus on both red and white cell indices, as well as platelet count. Citation: MacArthur V, Butler ...

In haematology, enhanced understanding of haematopoiesis and blood cell dynamics has been achieved through the advent of next‐generation sequencing, quantitative single‐cell analyses and ...

An early phase randomized clinical trial involving 130 patients with sickle cell disease found that the drug, ... The Lancet Haematology, 2024; DOI: 10.1016/S2352-3026(24)00045-0; ...

The 65th annual Haematocon conference in Nagpur gathers over 40 international experts in haematology to discuss advancements in sickle cell disease treatment and patient empowerment, emphasizing ...